Navigation Links
'Clinical and Economical Considerations For IV Push Drug Delivery' by Industry Expert Richard Rosenfeld Is Now Accessible on Expert411.com for Media and Professional Use
Date:12/27/2007

ENGLEWOOD, Colo., Dec. 27 /PRNewswire/ -- The "Clinical and Economical Considerations For IV Push Drug Delivery" technical paper -- authored by Industry Expert Richard Rosenfeld, RPh, MBA, for Baxa Corporation -- is now accessible at http://expert411.com/_wsn/page16.html for media and professional reference. The paper is an overview of the historical background for IV push and a model for implementation of a successful program.

IV push of cephalosporin antibiotics and other drugs is an alternative method of administration that can be safe, efficacious and cost effective. This paper concentrates on IV push of cefazolin as a case study, since it is a high-use cephalosporin with physical and chemical properties similar to other drugs that can be administered by the IV push method.

Rosenfeld has personally implemented the use of IV push antibiotics within two hospital systems. During the first year that this IV push program was in place, more than 50,000 doses of cefazolin were administered by the IV push method with no occurrences of phlebitis or adverse drug events directly associated with the change in the administration method of this drug. The paper discusses the economical advantages of moving to IV push, as well as the resulting nurse satisfaction and patient benefits seen through the resulting research followup.

Executive Director of Pharmacy Management for the Scripps Health Hospital System in San Diego, CA, Rosenfeld has responsibility for all system pharmacy services through his position with Cardinal Technology and Services. Prior to joining the Scripps Health team, he served as a consultant at Sharp Healthcare, a five-hospital IDN in San Diego, California, where the IV push method of administration for cephalosporins was implemented.

Rosenfeld earned a BS in Pharmacy from Ferris State University and a BA in Chemistry from San Diego State University. He holds
'/>"/>

SOURCE Baxa Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
3. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
4. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
5. PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials
6. Clinical Data Acquires Epidauros Biotechnologie AG, Significantly Enhancing Proprietary Genetic Biomarker Portfolio
7. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
8. Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs
9. Lorus Advances Clinical Development of GTI-2040 Combined with Ara-C in Acute Myeloid Leukemia
10. YM BioSciences USA cleared by US FDA to initiate Phase II clinical trial of nimotuzumab in children with inoperable, recurrent brain cancer
11. New Study Findings Confirm CLEXANE(R)/LOVENOX(R) Long-Term Clinical Benefit in Patients Suffering From Acute Coronary Syndrome

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...na, Dec. 2 /PRNewswire-Asia/ -- Simcere Pharmaceut...CR ), a leading pharmaceutical company,specializin... of branded,generic and proprietary pharmaceutical...have been included in China,s National Drug Reimbu... Ministry of Human Resources and Social,Security o...
(Date:12/2/2009).... 2 According to the National Inst...cans diagnosed with diabetes already have some sta... damage to the retina caused by leaky blood vessel...abetes and is one of the most feared diabetic comp...nts who,ve had diabetes for 10 years or more will ...
(Date:12/1/2009).... 1 Reportlinker.com announces tha... catalogue: ,, Industrial Enzymes - A Global M...0164431/Industrial-Enzymes---A-Global-Market-Repor...opoly with few strong players and a host of small ... competition and commoditization characterize the ...
(Date:12/1/2009)...y Leader Richard Gephardt Brings Together A-List f...ities for "Best and Brightest Forum on Medical In...swire-USNewswire/ -- Several of New Jersey,s most ... medicine and technology gathered today at the Lib...edical innovation in New Jersey, and throughout th...
Breaking Biology Technology:Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 2Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 4Reportlinker Adds Industrial Enzymes - A Global Market Report 2Reportlinker Adds Industrial Enzymes - A Global Market Report 3Reportlinker Adds Industrial Enzymes - A Global Market Report 4Reportlinker Adds Industrial Enzymes - A Global Market Report 5Reportlinker Adds Industrial Enzymes - A Global Market Report 6Reportlinker Adds Industrial Enzymes - A Global Market Report 7Reportlinker Adds Industrial Enzymes - A Global Market Report 8Reportlinker Adds Industrial Enzymes - A Global Market Report 9Reportlinker Adds Industrial Enzymes - A Global Market Report 10New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 2New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 3New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 4New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 5
... /Xinhua-PRNewswire-FirstCall/ -- China,Pharma Hol...CPHI), a,specialty pharmaceutical company which de...China, today announced that senior management will... conferences., -- Rodman and Renshaw,s Annual Gl...ack) will be held November 10-12, 2008 at the New ...
...tudy success at Berlin conference, RALEIGH, N.C.,...earch Organization announces it will present durin...- 7 November, 2008 in Berlin,Germany. PRA,s Christ...opment - Europe, will present "What,s next in the ...y, 5 November. Drawing on his extensive,experience...
... Network,s 3-Minute,Press Show is a daily program ...res in-depth interviews with public company execut...es., The show is designed to provide viewers with...act on the company,s growth., Shows air Monday...ress/3-min-press.php , The following executives w...
Other Biology Technology:China Pharma Holdings, Inc. to Present at Two Upcoming U.S. Investor Conferences 2China Pharma Holdings, Inc. to Present at Two Upcoming U.S. Investor Conferences 3PRA International Addresses Sponsor-CRO Partnering Strategies at European Partnerships in Clinical Trials Congress 2[video] Wall St. Network's 3-Minute Press Show Features Executive Interviews and Highlights Recent Press for the Following: GTHR, BHRT, AGO 2
(Date:12/2/2009)..., REDWOOD SHORES, Calif. and PALM HARBOR, Fla., De...ligence Corporation ("CIC") (OTC Bulletin Board: C...olutions for business process automation in the fi...iometric signature verification and Docubase Syste...tronic Document Management (EDM) software provider...
(Date:12/2/2009)...ember 2, 2009 Commonly prescribed beta 2 adrenerg...egnant women as well as pre-term labor may increas...hiatric pathology, cognitive problems and poor sch...new study published in the December 2009 issue of ... , Beta 2 adrenergic agonist drugs as a class ar...
(Date:12/2/2009)... HOBOKEN, NJ According to the National Institute ...iagnosed with diabetes already have some stage of ...e to the retina caused by leaky blood vessels, is ... and is one of the most feared diabetic complicati...o,ve had diabetes for 10 years or more will experi...
Breaking Biology News(10 mins):CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 2CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 3CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 4Treatments for asthma and pre-term labor may increase risk of autism in developing fetus 2Study shows pine bark improves circulation, swelling and visual acuity in early diabetic retinopathy 2Study shows pine bark improves circulation, swelling and visual acuity in early diabetic retinopathy 3Rescuing male turkey chicks 10864 1Rescuing male turkey chicks 10864 2An Incident of Road Rage Turns Into Murder 61937 1An Incident of Road Rage Turns Into Murder 61937 2Ann Taylor Stores Corp Returns To St Jude Childrens Research Hospitals Thanks and Giving Campaign 28R 29 For The Third Year 61935 1Ann Taylor Stores Corp Returns To St Jude Childrens Research Hospitals Thanks and Giving Campaign 28R 29 For The Third Year 61935 2
...s of biologists around the globe run DNA sequences...ne algorithm called BLAST ?typically submitting 20... to be matched against the billions of letters for...shed light on functional or evolutionary relations...ugh and produce vast amounts of data. Everyday app...
...row (21 July) will outline for the first time the ...shoulders in vertebrates. The scientists believe t...keletal and muscle structure separately they actua...posite,. This could have significant implications ...tebrate evolution. , Scientists at the Wolfson Ins...
...he Oregon National Primate Research Center, Oregon...ses of vitamin C may have potential to counteract ... The research may benefit thousands of babies born...ancy despite physician warnings. The research is p...urnal of Respiratory and Critical Care Medicine. ,...
Other Biology News:Drawing with DNA: 'Bioart' illuminates genomics 2Drawing with DNA: 'Bioart' illuminates genomics 3Scientists discover stem cell origin of neck and shoulders 2OHSU research shows vitamin C counteracts some negative impacts of smoking on unborn babies 2OHSU research shows vitamin C counteracts some negative impacts of smoking on unborn babies 3
PROTEAN II xi Cell, 16 cm, without spacers and combs from Bio-Rad
CleanCut Agarose, 2%, 12 ml from Bio-Rad
Safire 2 from Tecan
...h pressure dual piston pump and the Adept CE 4200 ... The system is provided with PowerStream data proc... CE 4901 PowerStream software operating in Windows...ers the same data processing power as the CE 4900 ...
Biology Products: